This study describes the clinical characteristics and microscopic findings of nails from 25 patients with palmoplantar pustulosis. Methods: This is a cross-sectional study of adult patients with clear-cut palmoplantar pustulosis. Onychodystrophy severity was evaluated in fingernails using the nail psoriasis severity index (NAPSI). A fragment of the most dystrophic fingernail was collected from each patient and submitted to routine histotechnical processing. The following microscopic parameters were evaluated: nail plate and subungual region thickness, presence or absence of parakeratosis, number of layers of parakeratosis, and presence of neutrophils, serous lakes, bacteria, blood, and fungi. Results: Twenty-one patients (84%) presented onychodystrophy with a mean NAPSI score of 12.67. The most common nail change was pitting (76.19% of patients). On average, nail plate thickness and subungual region thickness measured 0.42 and 0.14 mm, respectively. Neutrophils and fungi were not observed, but serous lakes were found in 4.7%, bacteria in 28.57%, blood in 4.76%, and parakeratosis in 19.05% of the patients. Conclusions: although palmoplantar pustulosis is a disease with great amounts of neutrophils in the epidermis, those cells were not found in the nail clippings studied herein. Furthermore, when clinical aspects and microscopic findings of palmoplantar pustulosis are compared to those of similar studies in psoriasis vulgaris, they show different characteristics.

Palmoplantar pustulosis represents a localized form of psoriasis with an estimated prevalence of 0.01–0.05% [1-5]. The involvement of nails is frequent in patients with psoriasis and is found in approximately 56% of cases in psoriasis vulgar [6], the most common cutaneous manifestation, whereas in palmoplantar pustulosis it occurs in 30–76% of patients [7]. The main goal of the present study is to describe the microscopic findings and clinical characteristics of nails from patients with palmoplantar pustulosis. To the best of our knowledge, this is the first detailed study describing nail changes associated with this specific form of psoriasis in the literature.

This is a cross-sectional study of patients diagnosed with palmoplantar pustulosis [3] and followed up in a dermatology outpatient hospital in Brazil (Hospital Universitário Evangélico de Curitiba, Paraná).

Patients were selected between August 2016 and August 2017 (consecutive cases) and data such as age, sex, duration of disease, and presence or absence of arthritis were collected. Onychodystrophy severity was evaluated in fingernails using the nail psoriasis severity index (NAPSI) [8].

A fragment of the most dystrophic fingernail was collected from each patient. When nails were clinically normal, nail fragments were systematically collected from the second finger of the nondominant hand.

Nail clipping was performed by cutting the distal portion of the free edge of the nail plate, with a minimum size of 5 mm in length and 2 mm in width [9, 10]. The nail samples were technically processed for microscopic observation as previously described [11]. The following microscopic parameters were evaluated: nail plate and subungual region thickness (measured in millimeters using an appropriate ruler), presence or absence of parakeratosis (corneocyte nuclei at the subungual region), number of layers of parakeratosis, and presence of neutrophils, serous lakes, bacteria, blood, and fungi. Microscopic examination was performed blindly.

Categorical variables, with nominal or ordinal measurement scales, were analyzed using the χ2 test, or Fisher’s exact test when the χ2 test could not be applied. Quantitative variables were analyzed using the Mann-Whitney test. When significant differences were observed, supplementary comparisons were performed using the least significant difference test. All tests were performed at p ≤ 0.05.

Twenty-five patients with palmoplantar pustulosis were included. Twenty-two were women and 3 were men, with ages varying between 18 and 74 years (46.24 ± 13.68 years). The duration of the disease ranged from 6 months to 19 years (6.6 ± 7.73 years). Arthritis was recorded in 16% of the patients.

Twenty-one patients (84%) presented onychodystrophy with NAPSI scores varying from 5 to 23 (12.67 ± 5.16). The most common nail changes were pitting (76.19%), leukonychia (38.1%), onycholysis (33.33%), crumbling and splinter hemorrhages (23.81%), Beau’s lines (14.29%), oil drop discoloration, and red spots in the lunula (9.52%).

The microscopic thickness of the nail plate ranged from 0.2 to 0.8 mm (0.42 ± 0.17 mm), and that of the subungual region from 0 to 0.6 mm (0.14 ± 0.16 mm).

Neutrophils and fungi were not observed, but serous lakes were found in 4.7%, bacteria in 28.57%, blood in 4.76%, and parakeratosis in 19.05% of the patients (number of layers varying from 3 to 6, mean: 4.25). Prominent arching of the nail transition zone was observed in 9.52% of the patients with onychodystrophy. Some microscopic findings can be seen in Figures 1 and 2.

Fig. 1.

Dystrophic nail from a patient with palmoplantar psoriasis showing a thick subungual region with blood. HE. Original magnification, ×20.

Fig. 1.

Dystrophic nail from a patient with palmoplantar psoriasis showing a thick subungual region with blood. HE. Original magnification, ×20.

Close modal
Fig. 2.

Dystrophic nail from a patient with palmoplantar psoriasis depicting prominent arching of the nail transition zone. HE. Original magnification, ×10.

Fig. 2.

Dystrophic nail from a patient with palmoplantar psoriasis depicting prominent arching of the nail transition zone. HE. Original magnification, ×10.

Close modal

Palmoplantar pustulosis shares many features with psoriasis vulgaris, and about one third of patients with palmoplantar pustulosis present typical psoriasis lesions elsewhere in the body (skin, nail, or joint changes). However, on a genetic level, one of the major allelic determinants of psoriasis susceptibility – the psoriasis susceptibility locus (PSORS) 1, which carries HLA-Cw*0602 – has not been found to be involved in the development of palmoplantar pustulosis [2-5]. Moreover, patients with palmoplantar pustulosis do not respond as well to the therapies usually employed in psoriasis vulgaris, and differ by having a female predominance and a stronger association with smoking.

In the population analyzed in this study, we found a much higher incidence of the disease in women (88%), with an average age of 46 years, when compared to reports from the literature [12, 13]. On the other hand, the average duration of disease and arthritis rates are in agreement with previous reports [14, 15].

Nail changes were observed in 84% of our patients, which is a higher percentage than the 30% found in other studies for palmoplantar pustulosis [7, 16]. The reason for this elevated rate in the onychodystrophy index could not be determined. Some possible reasons are (a) the small number of studies that have examined patients with palmoplantar pustulosis, preventing the establishment of reliable statistics; (b) the focus of the study on nail changes in this particular population; and (c) since this is the first study to analyze palmoplantar pustulosis patients in Brazil, the results could indicate a characteristic genetic profile more prone to onychodystrophy in Southern Brazil.

Most patients with onychodystrophy due to palmoplantar pustulosis from previous studies presented alterations due to nail matrix involvement. Burden and Kemmett [16] observed onycholysis and pitting in almost 40% of patients with that disease, and another study [7] found that 42.9% of patients presented pitting and 50% presented onycholysis. We observed similar results, finding pitting and onycholysis in 76 and 33% of our patients, respectively.

The average NAPSI for patients with pustulosis palmoplantar is not mentioned in the literature, but in this research we found an average of 12.67. Published data of NAPSI values for psoriasis vulgaris are variable according to the study, with scores ranging from 26.6 to 30.6 [17, 18]. A comparison of these values between the two forms of psoriasis should be conducted very cautiously, though, because the methods chosen for evaluation vary among studies.

Some studies claim that severity in nail involvement is a predictor of psoriatic arthritis prevalence [19], although common nail and joint autoantigens were never identified [20, 21]. Coincidently or not, we found a low prevalence of arthritis among our patients (16%) and a low NAPSI index (12.67 on average). Other authors [13] report a prevalence of 13–64% of arthritis in pustulosis palmoplantar, and some studies have demonstrated a greater nail involvement (high NAPSI score) in patients with psoriatic arthritis [19].

Few studies have reported microscopic observations of nail changes in nail inflammatory diseases [22-26]. Specific studies that have examined psoriasis are even rarer. Machler et al. [22] were the first to describe nail microscopic findings for psoriasis, reporting the presence of parakeratosis and neutrophils without other microscopic details. Werner et al. [23] described detailed nail microscopic findings of dystrophic nails from patients with psoriasis. A comparison between the microscopic changes observed in patients with psoriasis vulgaris by Werner et al. [23] and in patients with palmoplantar pustulosis from the present study is presented in Table 1. In general, it appears that nails in palmoplantar pustulosis are microscopically less altered than those in psoriasis vulgaris. This could be an explanation for the low NAPSI score found in this study.

Table 1.

Comparison of microscopic nail clipping findings in patients with psoriasis vulgaris and onychodystrophy and patients with palmoplantar pustulosis and onychodystrophy

Comparison of microscopic nail clipping findings in patients with psoriasis vulgaris and onychodystrophy and patients with palmoplantar pustulosis and onychodystrophy
Comparison of microscopic nail clipping findings in patients with psoriasis vulgaris and onychodystrophy and patients with palmoplantar pustulosis and onychodystrophy

Neutrophils are important cells in the physiopathology of palmoplantar pustulosis. The characteristic pustules of the disease consist of large intraepidermal collections of neutrophils. T-cell infiltrates in the dermis and epidermis play another important role, secreting several cytokines (IFN-γ, IL-6, IL-17, and TNF-α) that act as inflammation drivers in palmoplantar pustulosis [27]. Interestingly, whereas neutrophils were observed in nails of 12% of the patients with psoriasis vulgaris [23], they were never observed in nails from patients with palmoplantar pustulosis. This is likely a paradox, since palmoplantar pustulosis is the putative form of psoriasis presenting more neutrophils, and characteristically involves fingers and toes, close to the nail apparatus [22].

In conclusion, to the best of our knowledge, palmoplantar pustulosis presents less severe onychodystrophy and different microscopic characteristics when compared to psoriasis vulgaris. NAPSI seems to be lower in palmoplantar pustulosis and there is higher incidence of neutrophils, bacteria, and serous lakes, and more prominent parakeratosis in nails from patients with psoriasis vulgaris. Maybe our results add up to the differences between palmoplantar pustulosis and psoriasis vulgaris, as indicated by the already described distinct genotypic and phenotypic findings, and the low response to therapies regularly used in the treatment of the latter.

The authors thank Andre Antunes, histotechnician, for being deeply committed to his profession. They are also grateful to Dr. Lincoln Fabricio, Professor of Dermatology from Hospital Evangélico de Curitiba, Faculdade Evangélica do Paraná, for technical and academic support in performing this research, and the Brazilian Society of Dermatology for encouraging research.

Subjects gave their written informed consent. The study was approved by the local Research Ethics Committee (Registration No. 1.601.733).

The authors have no conflicts of interest to declare.

This study was sponsored by the Support Fund for Dermatology (Funaderm), Brazilian Society of Dermatology. The research fund follows the rule search of the Brazilian federal government.

Anber A. Tanaka and Betina Werner: substantial contributions to the conception and design of the work; the acquisition, analysis, and interpretation of data; and drafting and revising the work. Cassio Tornesy and Cassia Farris: substantial contributions to the acquisition, analysis, and interpretation of data, and drafting and revising the work.

All authors agreed to be accountable for all aspects of the work and approved the final version.

1.
Mrowietz
U
,
van de Kerkhof
PC
.
Management of palmoplantar pustulosis: do we need to change?
Br J Dermatol
.
2011
May
;
164
(
5
):
942
6
.
[PubMed]
0007-0963
2.
Sugiura
K
.
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants
.
J Dermatol Sci
.
2014
Jun
;
74
(
3
):
187
92
.
[PubMed]
0923-1811
3.
Navarini
AA
,
Burden
AD
,
Capon
F
,
Mrowietz
U
,
Puig
L
,
Köks
S
, et al.;
ERASPEN Network
.
European consensus statement on phenotypes of pustular psoriasis
.
J Eur Acad Dermatol Venereol
.
2017
Nov
;
31
(
11
):
1792
9
.
[PubMed]
0926-9959
4.
Farley
E
,
Masrour
S
,
McKey
J
,
Menter
A
.
Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool
.
J Am Acad Dermatol
.
2009
Jun
;
60
(
6
):
1024
31
.
[PubMed]
0190-9622
5.
Adişen
E
,
Tekin
O
,
Gülekon
A
,
Gürer
MA
.
A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients
.
J Eur Acad Dermatol Venereol
.
2009
Jul
;
23
(
7
):
814
9
.
[PubMed]
0926-9959
6.
Uber
M
,
Carvalho
VO
,
Abagge
KT
,
Robl Imoto
R
,
Werner
B
.
Clinical features and nail clippings in 52 children with psoriasis
.
Pediatr Dermatol
.
2018
Mar
;
35
(
2
):
202
7
.
[PubMed]
0736-8046
7.
Hiraiwa
T
,
Yamamoto
T
.
Nail involvement associated with palmoplantar pustulosis
.
Int J Dermatol
.
2017
Feb
;
56
(
2
):
e28
9
.
[PubMed]
0011-9059
8.
Rich
P
,
Scher
RK
.
Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis
.
J Am Acad Dermatol
.
2003
Aug
;
49
(
2
):
206
12
.
[PubMed]
0190-9622
9.
Fillus Neto
J
,
Tchornobay
AM
.
Como o clipping pode auxiliar o dermatologista
.
An Bras Dermatol
.
2009
;
84
(
2
):
173
6
.
[PubMed]
0365-0596
10.
Stephen
S
,
Tosti
A
,
Rubin
AI
.
Diagnostic applications of nail clippings
.
Dermatol Clin
.
2015
Apr
;
33
(
2
):
289
301
.
[PubMed]
0733-8635
11.
Werner
B
,
Antunes
A
.
Microscopic examination of normal nail clippings
.
Dermatol Pract Concept
.
2013
Jul
;
3
(
3
):
9
14
.
[PubMed]
2160-9381
12.
Olazagasti
JM
,
Ma
JE
,
Wetter
DA
.
Clinical Features, Etiologic Factors, Associated Disorders, and Treatment of Palmoplantar Pustulosis: The Mayo Clinic Experience, 1996-2013
.
Mayo Clin Proc
.
2017
Sep
;
92
(
9
):
1351
8
.
[PubMed]
0025-6196
13.
Brunasso
AM
,
Puntoni
M
,
Aberer
W
,
Delfino
C
,
Fancelli
L
,
Massone
C
.
Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study
.
Br J Dermatol
.
2013
Jun
;
168
(
6
):
1243
51
.
[PubMed]
0007-0963
14.
Michaëlsson
G
,
Kristjánsson
G
,
Pihl Lundin
I
,
Hagforsen
E
.
Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet
.
Br J Dermatol
.
2007
Apr
;
156
(
4
):
659
66
.
[PubMed]
0007-0963
15.
Richer
V
,
Roubille
C
,
Fleming
P
,
Starnino
T
,
McCourt
C
,
McFarlane
A
, et al.
Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity
.
J Cutan Med Surg
.
2016
May
;
20
(
3
):
221
7
.
[PubMed]
1203-4754
16.
Burden
AD
,
Kemmett
D
.
The spectrum of nail involvement in palmoplantar pustulosis
.
Br J Dermatol
.
1996
Jun
;
134
(
6
):
1079
82
.
[PubMed]
0007-0963
17.
Brazzelli
V
,
Carugno
A
,
Alborghetti
A
,
Grasso
V
,
Cananzi
R
,
Fornara
L
, et al.
Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: italian experience
.
J Eur Acad Dermatol Venereol
.
2012
Nov
;
26
(
11
):
1354
9
.
[PubMed]
0926-9959
18.
van der Velden
HM
,
Klaassen
KM
,
van de Kerkhof
PC
,
Pasch
MC
.
Fingernail psoriasis reconsidered: a case-control study
.
J Am Acad Dermatol
.
2013
Aug
;
69
(
2
):
245
52
.
[PubMed]
0190-9622
19.
Maejima
H
,
Taniguchi
T
,
Watarai
A
,
Katsuoka
K
.
Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index
.
Int J Dermatol
.
2010
Aug
;
49
(
8
):
901
6
.
[PubMed]
0011-9059
20.
McGonagle
D
,
Benjamin
M
,
Tan
AL
.
The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?
Curr Opin Rheumatol
.
2009
Jul
;
21
(
4
):
340
7
.
[PubMed]
1040-8711
21.
McGonagle
D
,
Palmou Fontana
N
,
Tan
AL
,
Benjamin
M
.
Nailing down the genetic and immunological basis for psoriatic disease
.
Dermatology
.
2010
;
221
Suppl 1
:
15
22
.
[PubMed]
1018-8665
22.
Machler
BC
,
Kirsner
RS
,
Elgart
GW
.
Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity
.
Cutis
.
1998
Apr
;
61
(
4
):
217
9
.
[PubMed]
0011-4162
23.
Werner
B
,
Fonseca
GP
,
Seidel
G
.
Microscopic nail clipping findings in patients with psoriasis
.
Am J Dermatopathol
.
2015
Jun
;
37
(
6
):
429
39
.
[PubMed]
0193-1091
24.
Laporte
M
,
André
J
,
Stouffs-Vanhoof
F
,
Achten
G
.
Nail changes in alopecia areata: light and electron microscopy
.
Arch Dermatol Res
.
1988
;
280
Suppl
:
S85
9
.
[PubMed]
0340-3696
25.
Miteva
M
,
de Farias
DC
,
Zaiac
M
,
Romanelli
P
,
Tosti
A
.
Nail clipping diagnosis of onychomatricoma
.
Arch Dermatol
.
2011
Sep
;
147
(
9
):
1117
8
.
[PubMed]
0003-987X
26.
Lin
AM
,
Rubin
CJ
,
Khandpur
R
,
Wang
JY
,
Riblett
M
,
Yalavarthi
S
, et al.
Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis
.
J Immunol
.
2011
Jul
;
187
(
1
):
490
500
.
[PubMed]
0022-1767
27.
Murakami
M
,
Hagforsen
E
,
Morhenn
V
,
Ishida-Yamamoto
A
,
Iizuka
H
.
Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum
.
Exp Dermatol
.
2011
Oct
;
20
(
10
):
845
7
.
[PubMed]
0906-6705

Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.